Remember when you had to really dig in concentrate and understand exactly how C# and other code worked at the most basic levels? Then you'll like Microsoft's early preview of .NET 11.

With rapid technological changes in the digital world, the need for a higher position on search engines has become a must rather than a choice. Companies from Mumbai are encountering difficulties in ...

"A regression in the Microsoft.AspNetCore.DataProtection 10.0.0-10.0.6 NuGet packages cause the managed authenticated ...

Threat actors are abusing external Microsoft Teams collaboration to impersonate IT helpdesk staff and convince users to grant ...

UGC-NET Final Answer Key: The National Testing Agency (NTA) has released the revised final answer key for the University Grants Commission-National Eligibility Test (UGC-NET) December 2025 session for ...

Q1 2026 Earnings Call April 23, 2026 5:00 PM EDTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...

The final day of the 2026 General Assembly session was Thursday — and into early Friday morning. We spent the day (and night) watching what lawmakers were going to do with big-ticket items such as tax ...

It's the end of another week, and as usual, the KDE team spent the last few days working on different parts of the KDE ecosystem, with a bulk of the work going to Plasma. Starting with Plasma 6.7, the ...

Error occured during this request! Please try again later. ERBIL, Kurdistan Region - Iraq’s parliament on Monday set April 11 as the date for a session to elect the ...

JEE Main April Session Admit Card 2026: The National Testing Agency (NTA) will release the Joint Entrance Examination (JEE) Mains April session 2026 examination admit card anytime soon. Once released, ...

MANILA, Philippines – Sen. Bato dela Rosa was absent for 31 days during the 20th Congress’ first regular session, according to Senate records. The absences were recorded from July 28, 2025, to March ...

Featured presentation highlights positive BroADen Phase 1b atopic dermatitis trial results supporting KT-621’s compelling oral profile Parallel Phase 2b trials, BROADEN2 in atopic dermatitis and ...